Grail's reply to editorial on "liquid biopsy" for cancer screening
- PMID: 33658189
- DOI: 10.1136/bmj.n596
Grail's reply to editorial on "liquid biopsy" for cancer screening
Conflict of interest statement
Competing interests: I am an executive and shareholder in Grail.
Comment on
-
"Liquid biopsy" for cancer screening.BMJ. 2021 Jan 4;372:m4933. doi: 10.1136/bmj.m4933. BMJ. 2021. PMID: 33397684 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical